France moves towards harmonising law on ownership of inventions and software

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

France moves towards harmonising law on ownership of inventions and software

Sponsored by

beau-de-lomenie.png
binary-code-4826796-1280.jpg

New rules now apply in France to inventions and software created by individuals who are neither private nor state sector employees, as Gaston Vedel of Cabinet Beau de Loménie explains

Order No. 2021-1658 of December 15 2021 concerns the attribution of IP rights relating to assets generated by software developers and inventors who are neither company employees nor civil servants and who have been working in a company or public institute carrying out research. This order has introduced new provisions into the French Intellectual Property Code (CPI), namely Articles L 113-9-1 and L 611-7-1.

These new provisions seek to extend the existing rules concerning patentable inventions (Article L 611-7 CPI) and software (Article L 113-9 CPI) created by public or state sector employees to other categories of authors and inventors.

These categories include interns, PhD students, scholarship students from overseas and emeritus professors or directors, who have been working in a company or public institute carrying out research acting as a host institution.

The new provisions provide that the host institution will own inventions or software created by an inventor or author in the context of their regular activities/mission or on the basis of explicit instructions given by the host institution. They also provide for the possible assignment to the host institution of certain inventions not resulting from the regular activities of the inventor or from instructions that are explicitly entrusted to the inventor. 

These provisions will apply whatever the type of host institution having an R&D activity (public or private), provided that the inventor or developer is bound to the host institution by an agreement and, as regards software, that the author was working under the orders of a manager and received compensation for the work carried out.

The new provisions seek to simplify the situation for institutions carrying out research and to harmonise the situation with respect to staff members being company employees or civil servants.

An implementing decree is expected to define in more detail the nature of the financial compensation which will be due to the inventors or developers.

Articles L 113-9-1 and L 611-7-1 entered into force on December 17 2021 and apply to inventions or software created from this date.

 

Gaston Vedel

IP lawyer, Cabinet Beau de Loménie

E: gvedel@bdl-ip.com

 

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article